Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Roche Basel Switzerland

Roche’s autism drug scores FDA breakthrough status

Balovaptan could become the first drug to treat autism spectrum disorder

- PMLiVE

Amgen set for Kyprolis label boost after CHMP backing

Multiple myeloma treatment set to add new survival data

- PMLiVE

Linda Law joins Advicenne as US VP, clinical development and med affairs

She will oversee the biopharma’s developments with its dTRA candidate

Amryt Pharma appoints new regulatory affairs head

Derval O’Carroll joins the rare disease-focused biopharma from Retrophin

Fujitsu begins two-year medical AI research project

Partners with Kyoto University on R&D-focused work

Managing misconduct allegations

Best practices for conducting internal investigations

- PMLiVE

Lucid look set to expand their Macclesfield team

This week Business Unit Heads from Lucid Group met with potential candidates at their Macclesfield office to interview for a number of key roles within the organisation. The recruitment drive...

Lucid Group Communications Limited

- PMLiVE

Amazon’s healthcare move takes aim at US costs

Founder Jeff Bezos says it enters the realm ‘open-eyed’ about its difficulty

- PMLiVE

Chiesi’s ultra-rare genetic disorder therapy wins European backing

Lamzede is set to become the first approved therapy for Alpha-Mannosidosis

- PMLiVE

EC grants MSD’s Prevymis orphan product designation

The product will gain some market exclusivity benefits in CMV infection

Robert Freisen joins Ablynx

He will take the role of chief scientific officer, effective March 1

- PMLiVE

Akari Therapeutics strengthens board

Hires Michael Grissinger and Dr Peter Feldschreiber

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links